Symptoms of an allergic reaction to this drug include fever, nausea, vomiting, diarrhea, skin rash, extreme tiredness, achiness, stomach pain, swelling or trouble breathing.

Precautions:

Tell your doctor your medical history, including any allergies, liver disease, alcohol dependence and diabetes.

Limit alcohol intake, as it may intensify side effects of this drug.

If you must stop using this drug due to an allergic reaction, never use the drug again. Consult MD and see the "Warning Card".

This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor.

It is not known whether this drug is excreted into breast milk.

Avoid breast-feeding because breast milk can transmit HIV.

Consult your doctor or pharmacist before breast-feeding.

For information on Medic Alert(TM) call 1-800-854-1166.

In Canada call 1-800-668-1507..

Related Drugs:

Ziagen 300 mg Tablet - Prescription

Ziagen 100 mg/5 ml Solution, Oral - Prescription,

Generic Name: Abacavir Sulfate

docket

http://www.fda.gov/cder/orange/docket.pdf

patent, EXCLUS, EXPIRES, Pediatric Exclusivity, PATENT/PED EXCL, TRADE, INGREDIENT, APPL/PROD, information submitted prior, docket, patent TERM EXTENSION, NCE, NDF, NPP.

hp_jan01_drugs

http://www.turner-white.com/pdf/hp_jan01_drugs.pdf

patients, Zyprexa, Tamiflu, placebo, Trizivir, influenza, therapy, schizophrenia, abacavir, receiving, dose, adverse events, prophylaxis, Administration.

Approval was granted to Glaxo Wellcome (Research Triangle Park, NC) to market Trizivir (abacavir sulfate, lamivudine, and zidovudine) tablets.
Trizivir is contraindicated in patients with hypersensitivity to abacavir sulfate (Ziagen), one of Trizivir's components, which can cause a life-threatening or fatal reaction.
Eli Lilly and Company (Indianapolis, IN) received approval to market Zyprexa (olanzapine) for the long-term therapy and maintenance of treatment response of schizophrenia.
Following the observation period, 224 patients were randomized to Zyprexa 10 to 20 mg daily, and 102 patients were randomized to placebo.
The United States Food and Drug Administration approved marketing of Tamiflu (oseltamivir phosphate) capsules by Roche Pharmaceuticals, Inc (Nutley, NJ) and Gilead Sciences, Inc (Foster City, CA) for a new indication.

2002_03_01

http://www.boehringer-ingelheim.com/hiv/news/download/2002_03_01.pdf

VIRAMUNE, Boehringer Ingelheim, patients, regimens, efavirenz, arms, abacavir, protease inhibitor, antiretroviral agents, HIV-1 infection, hypersensitivity reactions, viral load, nevirapine, rash.

"Increasingly, physicians are looking for alternatives to protease inhibitor regimens due to their associated adverse event profiles.
In the multicenter, open-label study, 460 patients who had been previously exposed to a PI-based regimen and had a plasma viral load below limit of quantitation were randomized to three PI-sparing arms containing a VIRAMUNE- (n=155), efavirenz (n=156) or abacavir- (n=149) based regimen.
The PI-sparing regimens were generally well tolerated.
The most commonly seen adverse event were rash and elevation of transiminases, neuropsychiatric and hypersensitivity reactions in the nevirapine, efavirenz and abacavir arms, respectively.
VIRAMUNE is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Boehringer Ingelheim is committed to the research and development of novel antiretroviral agents.

123530

http://www.msds-gsk.com/123530.pdf

exposure, TRIZIVIR, hazard, eye, tablets, Protection, skin, Environment, ingredient, Exposure Controls, adverse effects, equipment, transport, Health.

If the exposed subject is fully conscious, give plenty of water to drink.
Physical form suggests that risk of inhalation exposure is negligible.
For larger amounts (multiple packages/pallets) of product: Since toxic, corrosive or flammable vapours might be evolved from fires involving this product and associated packaging, self contained breathing apparatus and full protective equipment are recommended for firefighters.
Wear protective clothing and equipment consistent with the degree of hazard.
Local regulations and procedures should be consulted prior to environmental release.
Observe all local and national regulations when disposing of this product.
The information and recommendations in this safety data sheet are, to the best of our knowledge, accurate as of the date of issue.

Report_1

http://web.mit.edu/utr/report/Report_1.pdf

aid, relief, Sudan, health, UTR, drugs, food, medications, initiatives, Haiti, UTR members, Afghanistan, refugees, supplies.

UTR members aid sufferers of poverty, disease, and war through active ìredistribution effortsîóstudent-led initiatives to redistribute relief supplies from first-world countries to developing nations.
In their first semester, student members of UTR participated in programs to bring earthquake relief supplies to victims of quakes in Ecuador and India, foodstuffs to the hungry in Sudan, and AIDS drugs to patients in Haiti.
Support went chiefly to the Self-Employed Women's Association (SEWA), the Janpath Citizen's Initiative, and other groups that supplied relief material, food, medical supplies, and temporary housing.
Kim, Jim Yong (ed.), et al. -Dying for Growth: Global Inequality and the Health of the Poor Cambridge: Common Courage Press, 2000.